Now you're killing me rjs...lol. We are not near commercialization yet, we haven't even gotten FDA approval for the application. Then we need to go thru their trials. Then during the manufacturing stage I would think the $625K comes into play. Then upon actual commercialization, we get $10M. That is how I read it.
And they state in another place...
Then this, which implies that only $2M is being paid since they only what $2M back if we don't get FDA application approval within 6 months.
And they state in another place...
Quote:(iv) The Parties hereby agree that a sum of USD$2,000,000 paid by BHSB to Generex is
not a deposit and cannot be forfeited in any manner and is to be treated as an advance
payment towards receiving the Vaccine in the event Generex meets and complies with
the requirements of the FDA.
Then this, which implies that only $2M is being paid since they only what $2M back if we don't get FDA application approval within 6 months.
Quote:(v) In the event Generex/NuGenerex fails to secure the necessary FDA approvals within
6 months or within an approved reasonable amount of time thereafter, from the
execution of this DLA and subsequently upon the request of BHSB, Generex shall
reimburse BHSB the USD$2,000,000 advance within 30 days upon demand from
BHSB.
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
